Value-based healthcare for bladder cancer patients undergoing robot-assisted radical cystectomy.

The Urothelial Carcinoma Working Group of the European Association of Urology - Young Academic Urologists (EAU-YAU) has performed a comprehensive cost analysis of robot-assisted radical cystectomy (RARC) across 11 European centres in 4 countries (Belgium, France, Netherlands and the United Kingdom) using patient-level data from 490 patients who underwent RARC by 14 trained surgeons between 2015 and 2020 [ [1] Mjaess G. Diamand R. Aoun F. Assenmacher G. Assenmacher C. Verhoest G. et al. Cost-analysis of robot-assisted radical cystectomy in Europe: A cross-country comparison. 2022https://doi.org/10.1016/j.ejso.2022.07.023 Abstract Full Text Full Text PDF Scopus (4) Google Scholar ]. Their laudable efforts deserve recognition; congratulations to the authors and their supporting teams who have worked tirelessly to improve urologic oncological care of their patients. Cost-analysis of robot-assisted radical cystectomy in Europe: A cross-country comparisonEuropean Journal of Surgical OncologyVol. 49Issue 8PreviewRobotic-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD) is surging worldwide. Aim of the study was to perform a multicentric cost-analysis of RARC by comparing the gross cost of the intervention across hospitals in four different European countries. Full-Text PDF